Search Within

Kenneth Ho-Ming Yu

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (28)
  2. Journal Article (26)
Groups
  1. Biostatistics Service (54)
  2. Center for Pancreatic Cancer Research (54)
  3. Department of Medicine (54)
  4. Epidemiology and Biostatistics (54)
  5. Gastrointestinal Oncology Service (54)
  6. Solid Tumor Oncology Division (54)

More Groups

People
  1. Eileen O'Reilly (53)
  2. Marinela Capanu (44)
  3. David Kelsen (29)
  4. Joanne Chou (27)
  5. Anna Varghese (26)
  6. Maeve Lowery (21)

More People

Years
  1. 2024 (5)
  2. 2023 (5)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (6)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Cancer (6)
  3. Clinical Cancer Research (4)
  4. Annals of Oncology (2)
  5. Clinical Colorectal Cancer (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. Wiley Blackwell (7)
  3. American Association for Cancer Research (4)
  4. Oxford University Press (4)
  5. Elsevier Inc. (3)
  6. MDPI (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Young-onset pancreas cancer (PC) in patients less than or equal to 50 years old at Memorial Sloan Kettering (MSK): Descriptors, genomics, and outcomes
    Meeting Abstract

    Varghese, A. M.; Singh, I.; Singh, R. R.; Capanu, M.; Chou, J. F.; Wong, W.; Stadler, Z. K.; Salo-Mullen, E. E.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A randomized, multicenter, phase II trial of gemcitabine (G), cisplatin (C) plus /- veliparib (V) in patients with pancreas adenocarcinoma (PDAC) and a known germline (g)BRCA/ PALB2 mutation
    Meeting Abstract

    O'Reilly, E. M.; Lee, J. W.; Zalupski, M.; Capanu, M.; Park, J.; Golan, T.; Tahover, E.; Lowery, M. A.; Chou, J. F.; Sahai, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pancreatic ductal adenocarcinoma (PDAC), BRCA: Detailed analysis and outcomes of cohort from Memorial Sloan Kettering Cancer Center (MSK)
    Meeting Abstract

    Momtaz, P.; O'Connor, C. A.; Chou, J. F.; Capanu, M.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Li, J.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA/PALB2 mutation
    Journal Article

    O'Reilly, E. M.; Lee, J. W.; Zalupski, M.; Capanu, M.; Park, J.; Golan, T.; Tahover, E.; Lowery, M. A.; Chou, J. F.; Sahai, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Association of pancreatic cancer stem cells with tumor stroma type
    Meeting Abstract

    Sahin, I. H.; Askan, G.; Chou, J. F.; Capanu, M.; Yu, K. H.; Basturk, O.; Iacobuzio-Donahue, C. A.; O'Reilly, E. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study of plasma KRAS as a prognostic biomarker in localized pancreas ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Gedvilaite, E.; Chou, J. F.; Capanu, M.; You, D.; Yu, K. H.; Varghese, A. M.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; Tsui, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes
    Journal Article

    Wong, W.; Lowery, M. A.; Berger, M. F.; Kemel, Y.; Taylor, B.; Zehir, A.; Srinivasan, P.; Bandlamudi, C.; Chou, J.; Capanu, M.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Long-term follow-up of FOLFIRINOX induction therapy for locally unresectable pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Cohen, N.; McIntyre, C. A.; Goldman, D. A.; Mithat, G.; Sadot, E.; O'Reilly, E.; Varghese, A.; Yu, K.; Balachandran, V. P.; D'Angelica, M. I.; more...
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
    Journal Article

    Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
    Gastric Cancer (2019)

    Fulltext@MSK | Save
  • Binimetinib plus gemcitabine and cisplatin phase I/II trial in patients with advanced biliary cancers
    Journal Article

    Lowery, M. A.; Bradley, M.; Chou, J. F.; Capanu, M.; Gerst, S.; Harding, J. J.; El Dika, I.; Berger, M.; Zehir, A.; Ptashkin, R.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save